Varex Imaging Corp. 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring on February 13, 2025, the date of Varex Imaging Corporation's 2025 Annual Meeting of Stockholders. The filing details the outcomes of shareholder votes and a corporate governance amendment.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting results rather than financial performance.
Material Changes and Voting Results
At the Annual Meeting, approximately 92% of eligible shares were represented. Key outcomes include:
- Director Elections: Stockholders elected seven directors (Kathleen L. Bardwell, Jocelyn D. Chertoff, Timothy E. Guertin, Jay K. Kunkel, Walter M. Rosebrough, Jr., Sunny S. Sanyal, and Christine A. Tsingos) to serve until the 2026 Annual Meeting.
- Executive Compensation: Stockholders approved the advisory vote on executive compensation and recommended an annual frequency for future advisory votes.
- Employee Stock Purchase Plan: The 2017 Employee Stock Purchase Plan, as amended, was approved.
- Officer Exculpation: Stockholders approved an amendment to the Certificate of Incorporation to limit or eliminate the monetary liability of certain officers for breaches of the fiduciary duty of care, to the fullest extent permitted under Delaware law.
- Auditor Ratification: Deloitte & Touche LLP was ratified as the independent registered public accounting firm for fiscal year 2025.
Guidance, Outlook, and Risks
The filing does not contain management guidance, financial outlook, or specific risk factors. The primary corporate action noted is the immediate effectiveness of the officer exculpation amendment upon filing with the Delaware Secretary of State.
Investor Verification Checklist
- Verify the full text of the Certificate of Amendment (Exhibit 3.1) to understand the specific scope of officer liability limitations.
- Review the Definitive Proxy Statement (Schedule 14A) filed on December 30, 2024, for detailed descriptions of the proposals and executive compensation data.
- Confirm the terms of the amended 2017 Employee Stock Purchase Plan referenced in Exhibit 10.1.
- Monitor future filings for the company's fiscal year 2025 financial results, as this 8-K contains no financial data.